Literature DB >> 31749524

Comparison of efficacy of ivermectin and diethylcarbamazine against naturally infected Brugia malayi microfilaria in dogs.

Poojary Vineeta Sadarama1, Deepa Chirayath1, Usha Narayana Pillai1, Bindu Lakshmanan2.   

Abstract

Filarial parasites like Brugia pahangi and Brugia malayi can infect dogs. Adults of Brugia genus resides in the lymphatic system and microfilariae, in blood. There are increasing reports of detection of B. malayi microfilariae in dogs. A study was undertaken to compare the efficacy of repeated oral dosing of ivermectin (IVT) and diethylcarbamazine (DEC), individually and in combination against naturally infected B. malayi microfilariae in dogs. The species of the microfilariae was confirmed by acid phosphatase staining and polymerase chain reaction. The three treatment groups were 200 mcg/kg body weight IVT daily for 14 days (I), 6.6 mg/kg body weight DEC daily for 14 days (II) and IVT and DEC together in the same dose for a period of 5 days (III). Microfilarial status of the peripheral blood was assessed on the 0th, 7th, 14th and 21st day. Haematological parameters were measured on day zero and on the 21st day. Though, all the three treatment groups showed a reduction in the microfilarial concentration through the study period, complete absence of detectable microfilaremia was not noticed in any of the three groups by 21st day. Among the haematological parameters, statistically significant difference was observed in the post-treatment means of haemoglobin levels of group III when compared with group II. Since group III regime (IVT + DEC) was shorter and just as effective as the longer ones, it is considered superior to the other two. © Indian Society for Parasitology 2019.

Entities:  

Keywords:  Brugia malayi; Diethylcarbamazine; Dog; Ivermectin; Microfilaricidal

Year:  2019        PMID: 31749524      PMCID: PMC6841773          DOI: 10.1007/s12639-019-01126-2

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  8 in total

1.  The efficacy of a single-oral-dose administration of ivermectin and diethylcarbamazine on the treatment of feline Brugia malayi.

Authors:  Gaysorn Chansiri; Phaisan Khawsak; Sirichai Phantana; Nopporn Sarataphan; Kosum Chansiri
Journal:  Southeast Asian J Trop Med Public Health       Date:  2005-09       Impact factor: 0.267

2.  Molecular phylogenetic studies on Brugia filariae using Hha I repeat sequences.

Authors:  H Xie; O Bain; S A Williams
Journal:  Parasite       Date:  1994-09       Impact factor: 3.000

3.  Histochemical differentiation of Dirofilaria immitis and Dipetalonema reconditum.

Authors:  L Chalifoux; R D Hunt
Journal:  J Am Vet Med Assoc       Date:  1971-03-01       Impact factor: 1.936

4.  Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis.

Authors:  Wilma A Stolk; Gerrit J VAN Oortmarssen; S P Pani; Sake J DE Vlas; S Subramanian; P K DAS; J Dik F Habbema
Journal:  Am J Trop Med Hyg       Date:  2005-11       Impact factor: 2.345

5.  Detection of human filarial parasite Brugia malayi in dogs by histochemical staining and molecular techniques.

Authors:  V R Ambily; Usha Narayana Pillai; R Arun; S Pramod; K M Jayakumar
Journal:  Vet Parasitol       Date:  2011-05-06       Impact factor: 2.738

6.  Tolerability and efficacy of single-dose diethyl carbamazine (DEC) or ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, south India.

Authors:  G Subramanyam Reddy; N Vengatesvarlou; P K Das; P Vanamail; A P Vijayan; S Kala; S P Pani
Journal:  Trop Med Int Health       Date:  2000-11       Impact factor: 2.622

7.  Successful treatment of Brugia pahangi in naturally infected cats with ivermectin.

Authors:  Piyanan Taweethavonsawat; Sudchit Chungpivat
Journal:  Korean J Parasitol       Date:  2013-12-31       Impact factor: 1.341

8.  Current evidence on the use of antifilarial agents in the management of bancroftian filariasis.

Authors:  Sumadhya Deepika Fernando; Chaturaka Rodrigo; Senaka Rajapakse
Journal:  J Trop Med       Date:  2010-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.